Abstract
Interferon alpha 2b gene (INF α2b) as a protein with antiviral and antitumor activities is potentially a valuable therapeutic protein to work on. Prior to having a large-scale production of the target protein, it is recommended to examine it on an experimental scale, so that a bacterial host could be a proper choice as it leads us to a deep insight into the subject. In this research, the INF α2b sequence was obtained from the NCBI gene data bank, and after optimization, it was subjected to be cloned and expressed in pET28a+. In order to primary examination of the target protein, Escherichia coli was considered a prokaryotic expression system. IPTG induction of the protein in bacteria cells containing the construct pET: IFN, followed by resolving total proteins through SDS-PAGE. The expected size of the investigated protein, about 24kDa, was observed through gel separation. Further assessment via western blotting confirmed the successful expression of IFN α2b.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
